|
AMBRA1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.49360000034626E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.971500E-04 |
| Normal-vs-Stage2 |
3.52240000000004E-05 |
| Normal-vs-Stage3 |
1.75209999953019E-07 |
| Normal-vs-Stage4 |
1.87066999999264E-05 |
| Stage1-vs-Stage2 |
5.532100E-02 |
| Stage1-vs-Stage3 |
2.302100E-02 |
| Stage1-vs-Stage4 |
1.180030E-01 |
| Stage2-vs-Stage3 |
8.583800E-01 |
| Stage2-vs-Stage4 |
6.450800E-01 |
| Stage3-vs-Stage4 |
7.182000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.03219999991744E-07 |
| Normal-vs-AfricanAmerican |
3.022200E-03 |
| Normal-vs-Asian |
8.370400E-01 |
| Caucasian-vs-AfricanAmerican |
6.152400E-01 |
| Caucasian-vs-Asian |
1.314970E-01 |
| AfricanAmerican-vs-Asian |
2.463800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.41100000759099E-09 |
| Normal-vs-Female |
1.421630E-03 |
| Male-vs-Female |
5.195100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.102500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.229290E-04 |
| Normal-vs-Age(61-80Yrs) |
1.1761999996196E-07 |
| Normal-vs-Age(81-100Yrs) |
8.31020000000571E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.455600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.809000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.776800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.518400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.200100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.453000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.188800E-01 |
| Normal-vs-Grade 2 |
1.75770999999436E-05 |
| Normal-vs-Grade 3 |
6.72260000000868E-07 |
| Normal-vs-Grade 4 |
8.67609999954944E-07 |
| Grade 1-vs-Grade 2 |
1.592460E-02 |
| Grade 1-vs-Grade 3 |
1.423930E-02 |
| Grade 1-vs-Grade 4 |
2.916300E-03 |
| Grade 2-vs-Grade 3 |
6.629000E-01 |
| Grade 2-vs-Grade 4 |
2.722600E-01 |
| Grade 3-vs-Grade 4 |
4.631400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.13039999999998E-05 |
| Normal-vs-ccB subtype |
1.25269999995403E-06 |
| ccA subtype-vs-ccB subtype |
3.541000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.43250000001127E-06 |
| Normal-vs-N1 |
5.417000E-03 |
| N0-vs-N1 |
6.499400E-01 |
|
|
